Hong Kong Pharmaceuticals Stock News

Innovent Biologics recently announced an exclusive license agreement granting Spero Therapeutics rights to develop and commercialize IBI355 outside Greater China, with Innovent eligible for up to approximately US$1.10 billion in upfront and milestone payments plus tiered royalties. The arrangement effectively turns IBI355 into a globally partnered asset, allowing Innovent to keep Greater China rights while leveraging Spero’s international development plans in IgG4-related disease and...

Q Technology (Group) (SEHK:1478) reported unaudited June 2026 sales data, with 41,500,000 camera module and LiDAR units and 11,961,000 biological recognition modules shipped, giving investors fresh insight into current operating activity. See our latest analysis for Q Technology (Group). At a share price of HK$7.01, Q Technology (Group) has seen short term momentum soften, with a 1 month share price return down 22.54% and year to date share price return down 18.96%, even though the 3 year...

Geely Automobile Holdings (SEHK:175) has expanded its partnership with Valvoline Global Operations, naming Valvoline as its designated lubricant technology partner across Asia Pacific. The agreement includes Geely’s Horse Powertrain joint venture and provides Valvoline with long term aftersales access across Geely’s vehicle network. Geely is also part of a surge in Chinese car exports that recently crossed 1,000,000 units in a single month, as European trade pressures prompt automakers to...

Guangzhou Innogen Pharmaceutical Group Co., Ltd ( HKG:2591 ) is possibly approaching a major achievement in its...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

With the business potentially at an important milestone, we thought we'd take a closer look at Jiangsu Guofu Hydrogen...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Insiders who bought HK$11.1m worth of B.Duck Semk Holdings International Limited's ( HKG:2250 ) stock at an average buy...

With the business potentially at an important milestone, we thought we'd take a closer look at Keymed Biosciences...

With the business potentially at an important milestone, we thought we'd take a closer look at CiDi Inc.'s ( HKG:3881...

Looking at Prime Intelligence Solutions Group Limited's ( HKG:8379 ) insider transactions over the last year, we can...

Chong Fai Jewellery Group Holdings Company Limited ( HKG:8537 ) recently posted some strong earnings, and the market...

From what we can see, insiders were net sellers in Shenzhen Dobot Corp Ltd's ( HKG:2432 ) during the past 12 months...

Despite the fact that Creative China Holdings Limited's (HKG:8368) value has dropped 11% in the last week insiders who...

Potential Unisound AI Technology Co., Ltd. ( HKG:9678 ) shareholders may wish to note that the Co-Founder, Wei Huang...

Insiders who bought Synertone Communication Corporation ( HKG:1613 ) stock lover the last 12 months are probably not as...

Maanshan Iron & Steel Company Limited ( HKG:323 ) is possibly approaching a major achievement in its business, so we...

The market was pleased with the recent earnings report from Café de Coral Holdings Limited ( HKG:341 ), despite the...

Quite a few insiders have dramatically grown their holdings in Lai Sun Development Company Limited ( HKG:488 ) over the...

Shareholders in New World Development Company Limited ( HKG:17 ) may be thrilled to learn that the analysts have just...

Analyst reports on China State Construction International Holdings (SEHK:3311) have put fresh focus on the stock after highlighting its diversification beyond mainland China, its growing presence in Hong Kong, Macau and Southeast Asia, and its exposure to Hong Kong’s Northern Metropolis infrastructure plans. See our latest analysis for China State Construction International Holdings. Despite the recent enthusiasm around China State Construction International Holdings, the latest HK$7.59 share...

Tencent Holdings (SEHK:700) is back in focus after reports it may invest over $2b in AI startup Manus and deepen its role in DeepSeek funding, reinforcing its push into Chinese AI models. See our latest analysis for Tencent Holdings. Tencent Holdings' latest AI investments come as the stock trades at HK$474.0, with a 1-day share price return of 3.90% but a year to date share price decline of 23.92%. The 3-year total shareholder return of 46.51% contrasts with a 1-year total shareholder return...

China’s Q2 GDP slowdown to 4.3%, soft consumer demand and ongoing real estate weakness are putting more focus on resilience and income rather than on rapid growth. For dividend investors looking at Chinese blue chips, that mix of slower expansion, strong exports and uncertain stimulus can change how reliable different stocks might feel. This article walks through 3 dividend paying Chinese blue chip stocks that appear positively exposed to these macro trends, explaining how each one could fit,...

HKR International (SEHK:480) has wrapped up FY 2026 with second half revenue of HK$1,021.9 million, Basic EPS of HK$0.15 and net income of HK$216.3 million, against a share price of HK$1.07. The company has seen revenue move from HK$900.9 million in the second half of FY 2025 to HK$1,021.9 million in the second half of FY 2026, while EPS shifted from a HK$0.21 loss to HK$0.15. This provides a clearer view of how margins are shaping up into the new year. See our full analysis for HKR...